6/4/25 16:05 | 6/2/25 | VCEL | Health | BioPrd | Biological Products, (No Diag | Hopper Jonathan Mark | MA | O | Chief Me | 2 | M.d | 581 | 29.05 | 0 | 20 | 43 | 66 | D | | | | | | | | | | | | | | |
6/4/25 16:05 | 6/2/25 | VCEL | Health | BioPrd | Biological Products, (No Diag | Hopper Jonathan Mark | MA | O | Chief Me | 2 | S.d | -581 | 29.05 | 0 | -20 | | 66 | D | | | | | | | | | | | | | | |
5/16/25 16:06 | 5/14/25 | VCEL | Health | BioPrd | Biological Products, (No Diag | Colangelo Dominick | MA | DO | P,CEO | 4 | M.dm | 3,452 | 22.18 | 0 | 156 | 149 | 260 | D | | | | | | | | | | | | | | |
5/16/25 16:06 | 5/14/25 | VCEL | Health | BioPrd | Biological Products, (No Diag | Colangelo Dominick | MA | DO | P,CEO | 4 | S.dm | -3,452 | 22.18 | 0 | -156 | | 260 | D | | | | | | | | | | | | | | |
5/9/25 16:05 | 5/7/25 | VCEL | Health | BioPrd | Biological Products, (No Diag | McLaughlin Kevin F | MA | D | | 3 | M.d | 299 | 17.39 | 0 | 17 | | 15 | D | | | | | | | | | | | | | | |
5/9/25 16:05 | 5/7/25 | VCEL | Health | BioPrd | Biological Products, (No Diag | McLaughlin Kevin F | MA | D | | 3 | S.d | -299 | 17.39 | 0 | -17 | | 15 | D | | | | | | | | | | | | | | |
5/2/25 16:07 | 4/30/25 | VCEL | Health | BioPrd | Biological Products, (No Diag | Hagen Heidi | MA | D | | 1 | M.d | 0 | 0.00 | 0 | 3 | 11 | 32 | D | | | | | | | | | | | | | | |
5/2/25 16:07 | 4/30/25 | VCEL | Health | BioPrd | Biological Products, (No Diag | Wright Lisa | MA | D | | 1 | M.d | 0 | 0.00 | 0 | 3 | 34 | 13 | D | | | | | | | | | | | | | | |
5/2/25 16:07 | 4/30/25 | VCEL | Health | BioPrd | Biological Products, (No Diag | Zerbe Robert L Md | MA | D | | 1 | M.d | 0 | 0.00 | 0 | 3 | 12 | 30 | D | | | | | | | | | | | | | | |
5/2/25 16:07 | 4/30/25 | VCEL | Health | BioPrd | Biological Products, (No Diag | Wotton Paul K | MA | D | | 1 | M.d | 0 | 0.00 | 0 | 3 | 12 | 31 | D | | | | | | | | | | | | | | |
5/2/25 16:06 | 4/30/25 | VCEL | Health | BioPrd | Biological Products, (No Diag | Rubino Alan L | MA | D | | 1 | M.d | 0 | 0.00 | 0 | 3 | 7 | 46 | D | | | | | | | | | | | | | | |